Science
CME credits: 0.25 Valid until: 23-12-2021 Claim your CME credit at https://reachmd.com/programs/cme/keeping-pace-gi-cancer-advances-immunotherapy-msi-hdmmr-metastatic-colorectal-cancer/12082/ Recent immunotherapy approvals have changed the treatment paradigm for first and subsequent lines of treatment for patients with microsatellite-high or mismatch repair deficient metastatic colorectal cancer. Join us as we deep dive into recent and newly emergent data to better understand how to bring these advances into the clinic.